Search results for the GEO ID: GSE30195
(Click on the check boxes provided under "Select for analysis", to initiate grouping)
(Once the selection is made, click on "Add groups" in "Make groups for comparison", to make a group. Scroll down)
GSM ID
GPL ID
Select for analysis
Title
Source name
Description
Characteristics
GSM747424
GPL570
no U2AF1 mutation 3 rep CD34+ purified MDS bone marrow upn: 127804 genotype: no U2AF1 mutation disease state: Myelodysplastic syndrome cell type: CD34+ purified MDS bone marrow age on study: 64 race: White banking date: 8/3/2005 diagnosis date: 2005-08-03 duration of disease (month): 0 Sex: male fab: RA bone marrow myeloblast(%): 2 wbc (x10^3/mcl): 2.3 platelet (x10^3/mcl): 195 hemoglobin (g/dl): 8.9 anc (x10^3/mcl): 1.4 iPSs: 0.5 cytogenetic risk group: Good cytogenetics: 46, XY[20]
GSM747425
GPL570
U2AF1 mutation 1 rep CD34+ purified MDS bone marrow upn: 300813 genotype: U2AF1 mutation disease state: Myelodysplastic syndrome cell type: CD34+ purified MDS bone marrow age on study: 41 race: White banking date: 7/12/2005 diagnosis date: 2005-04-26 duration of disease (month): 3 Sex: female fab: RA bone marrow myeloblast(%): 2 wbc (x10^3/mcl): 2.7 platelet (x10^3/mcl): 243 hemoglobin (g/dl): 12.2 anc (x10^3/mcl): 1.2 iPSs: 0 cytogenetic risk group: Good cytogenetics: 46, XX[20]
GSM747426
GPL570
U2AF1 mutation 17 rep CD34+ purified MDS bone marrow upn: 321864 genotype: U2AF1 mutation disease state: Myelodysplastic syndrome cell type: CD34+ purified MDS bone marrow age on study: 63 race: White banking date: 10/3/2005 diagnosis date: 2005-10-03 duration of disease (month): 0 Sex: female fab: RAEB bone marrow myeloblast(%): 12 wbc (x10^3/mcl): 1.9 platelet (x10^3/mcl): 56 hemoglobin (g/dl): 9.8 anc (x10^3/mcl): 0.3 iPSs: 2.5 cytogenetic risk group: Intermediate cytogenetics: 47,XX,+8[20]
GSM747427
GPL570
no U2AF1 mutation 12 rep CD34+ purified MDS bone marrow upn: 350460 genotype: no U2AF1 mutation disease state: Myelodysplastic syndrome cell type: CD34+ purified MDS bone marrow age on study: 30 race: Black banking date: 11/17/2006 diagnosis date: 2006-11-17 duration of disease (month): 0 Sex: male fab: RA bone marrow myeloblast(%): 4 wbc (x10^3/mcl): 2.1 platelet (x10^3/mcl): 37 hemoglobin (g/dl): 7.5 anc (x10^3/mcl): 1.6 iPSs: 0.5 cytogenetic risk group: Good cytogenetics: 46, XY[20]
GSM747428
GPL570
no U2AF1 mutation 10 rep CD34+ purified MDS bone marrow upn: 372440 genotype: no U2AF1 mutation disease state: Myelodysplastic syndrome cell type: CD34+ purified MDS bone marrow age on study: 59 race: White banking date: 5/5/2006 diagnosis date: 5/5/2006 duration of disease (month): 0 Sex: male fab: RA bone marrow myeloblast(%): 2 wbc (x10^3/mcl): 2.9 platelet (x10^3/mcl): 123 hemoglobin (g/dl): 13.8 anc (x10^3/mcl): 1.4 iPSs: 0 cytogenetic risk group: Good cytogenetics: 46,XY[20]
GSM747429
GPL570
no U2AF1 mutation 9 rep CD34+ purified MDS bone marrow upn: 421452 genotype: no U2AF1 mutation disease state: Myelodysplastic syndrome cell type: CD34+ purified MDS bone marrow age on study: 33 race: White banking date: 11/4/2005 diagnosis date: 2005-09-30 duration of disease (month): 2 Sex: female fab: RAEB bone marrow myeloblast(%): 10 wbc (x10^3/mcl): 3.3 platelet (x10^3/mcl): 22 hemoglobin (g/dl): 8.3 anc (x10^3/mcl): 0.9 iPSs: 1 cytogenetic risk group: Good cytogenetics: 46,XX[20]
GSM747430
GPL570
no U2AF1 mutation 5 rep CD34+ purified MDS bone marrow upn: 431137 genotype: no U2AF1 mutation disease state: Myelodysplastic syndrome cell type: CD34+ purified MDS bone marrow age on study: 54 race: White banking date: 8/29/2006 diagnosis date: 2006-07-05 duration of disease (month): 1 Sex: male fab: RAEB bone marrow myeloblast(%): 7 wbc (x10^3/mcl): 6.5 platelet (x10^3/mcl): 8 hemoglobin (g/dl): 8.2 anc (x10^3/mcl): 4.6 iPSs: 2 cytogenetic risk group: Poor cytogenetics: 46,XY,add(3)(q25),del(3)(p13),del(5)(q15q31),-6,+8,add(12)(p11.2),add(15)(p11.1), -18,+22[cp4]/44,sl,-8,-20,-22,+mar[cp5]/44,sl1,-del(3),-7,+2mar[cp5]/43,sl1,add(X)(q28),-add(12p),+12,-mar[cp6]
GSM747431
GPL570
no U2AF1 mutation 14 rep CD34+ purified MDS bone marrow upn: 497942 genotype: no U2AF1 mutation disease state: Myelodysplastic syndrome cell type: CD34+ purified MDS bone marrow age on study: 47 race: White banking date: 1/18/2006 diagnosis date: 2006-01-18 duration of disease (month): 0 Sex: male fab: RA bone marrow myeloblast(%): 0 wbc (x10^3/mcl): 4.1 platelet (x10^3/mcl): 24 hemoglobin (g/dl): 8.6 anc (x10^3/mcl): 1.6 iPSs: 1 cytogenetic risk group: Intermediate cytogenetics: 46,XY,der(1;22)(q10;q10)[4]/46,XY[16]
GSM747432
GPL570
no U2AF1 mutation 11 rep CD34+ purified MDS bone marrow upn: 667720 genotype: no U2AF1 mutation disease state: Myelodysplastic syndrome cell type: CD34+ purified MDS bone marrow age on study: 65 race: White banking date: 5/9/2006 diagnosis date: 2006-05-01 duration of disease (month): 0 Sex: female fab: RAEB bone marrow myeloblast(%): 10 wbc (x10^3/mcl): 5.1 platelet (x10^3/mcl): 61 hemoglobin (g/dl): 8.8 anc (x10^3/mcl): 2.3 iPSs: 1 cytogenetic risk group: Good cytogenetics: 46,XX[20]
GSM747433
GPL570
no U2AF1 mutation 8 rep CD34+ purified MDS bone marrow upn: 703653 genotype: no U2AF1 mutation disease state: Myelodysplastic syndrome cell type: CD34+ purified MDS bone marrow age on study: 20 race: White banking date: 2/2/2005 diagnosis date: 2005-02-02 duration of disease (month): 0 Sex: female fab: RA bone marrow myeloblast(%): 0 wbc (x10^3/mcl): 3 platelet (x10^3/mcl): 27 hemoglobin (g/dl): 8.4 anc (x10^3/mcl): 0.6 iPSs: 0.5 cytogenetic risk group: Good cytogenetics: 46,XX[20]
GSM747434
GPL570
no U2AF1 mutation 20 rep CD34+ purified MDS bone marrow upn: 705782 genotype: no U2AF1 mutation disease state: Myelodysplastic syndrome cell type: CD34+ purified MDS bone marrow age on study: 34 race: White banking date: 8/4/2006 diagnosis date: 2006-08-04 duration of disease (month): 0 Sex: male fab: RAEB bone marrow myeloblast(%): 5 wbc (x10^3/mcl): 3.3 platelet (x10^3/mcl): 28 hemoglobin (g/dl): 9.7 anc (x10^3/mcl): 1.7 iPSs: 1 cytogenetic risk group: Good cytogenetics: 46,XY[20]
GSM747435
GPL570
U2AF1 mutation 3 rep CD34+ purified MDS bone marrow upn: 843623 genotype: U2AF1 mutation disease state: Myelodysplastic syndrome cell type: CD34+ purified MDS bone marrow age on study: 59 race: White banking date: 3/3/2003 diagnosis date: 2003-03-03 duration of disease (month): 0 Sex: male fab: RAEB bone marrow myeloblast(%): 6 wbc (x10^3/mcl): 0.7 platelet (x10^3/mcl): 64 hemoglobin (g/dl): 9.7 anc (x10^3/mcl): 0.4 iPSs: 1 cytogenetic risk group: Good cytogenetics: 46,XY,del(20)(q11.2q13.3)[2]/46,XY[18]
GSM747436
GPL570
U2AF1 mutation 18 rep CD34+ purified MDS bone marrow upn: 917011 genotype: U2AF1 mutation disease state: Myelodysplastic syndrome cell type: CD34+ purified MDS bone marrow age on study: 80 race: White banking date: 6/2/2006 diagnosis date: 2006-06-02 duration of disease (month): 0 Sex: male fab: RA bone marrow myeloblast(%): 0 wbc (x10^3/mcl): 3.3 platelet (x10^3/mcl): 107 hemoglobin (g/dl): 8.2 anc (x10^3/mcl): 0.5 iPSs: 0.5 cytogenetic risk group: Good cytogenetics: 46,XY,del(20)(q11.2)[12]/46,XY[8]
GSM747437
GPL570
U2AF1 mutation 15 rep CD34+ purified MDS bone marrow upn: 937954 genotype: U2AF1 mutation disease state: Myelodysplastic syndrome cell type: CD34+ purified MDS bone marrow age on study: 50 race: White banking date: 9/20/2005 diagnosis date: 2005-09-12 duration of disease (month): 0 Sex: male fab: RAEB bone marrow myeloblast(%): 12 wbc (x10^3/mcl): 1.2 platelet (x10^3/mcl): 35 hemoglobin (g/dl): 9.9 anc (x10^3/mcl): 0.3 iPSs: 3 cytogenetic risk group: Poor cytogenetics: 47,XY,+8[1]/47,idem,del(16)(q12.1)[13]/48,idem,+Y,del(16)(q11.1)[5]/46,XY[1]
GSM747438
GPL570
U2AF1 mutation 16 rep CD34+ purified MDS bone marrow upn: 989739 genotype: U2AF1 mutation disease state: Myelodysplastic syndrome cell type: CD34+ purified MDS bone marrow age on study: 71 race: White banking date: 9/30/2005 diagnosis date: 2005-08-15 duration of disease (month): 1 Sex: male fab: RAEB bone marrow myeloblast(%): 18 wbc (x10^3/mcl): 1.2 platelet (x10^3/mcl): 52 hemoglobin (g/dl): 11 anc (x10^3/mcl): 0.2 iPSs: 3 cytogenetic risk group: Poor cytogenetics: 46,XY,del(7)(q21)[8]/46,XY[12]
GSM747439
GPL570
RNA control rep3 CD34+ purified control bone marrow genotype: control disease state: control cell type: CD34+ purified control bone marrow age on study: unknown race: unknown banking date: unknown diagnosis date: unknown duration of disease (month): unknown Sex: unknown fab: unknown bone marrow myeloblast(%): unknown wbc (x10^3/mcl): unknown platelet (x10^3/mcl): unknown hemoglobin (g/dl): unknown anc (x10^3/mcl): unknown iPSs: unknown cytogenetic risk group: unknown cytogenetics: unknown
GSM747440
GPL570
RNA control rep4 CD34+ purified control bone marrow genotype: control disease state: control cell type: CD34+ purified control bone marrow age on study: unknown race: unknown banking date: unknown diagnosis date: unknown duration of disease (month): unknown Sex: unknown fab: unknown bone marrow myeloblast(%): unknown wbc (x10^3/mcl): unknown platelet (x10^3/mcl): unknown hemoglobin (g/dl): unknown anc (x10^3/mcl): unknown iPSs: unknown cytogenetic risk group: unknown cytogenetics: unknown
GSM747441
GPL570
RNA control rep5 CD34+ purified control bone marrow genotype: control disease state: control cell type: CD34+ purified control bone marrow age on study: unknown race: unknown banking date: unknown diagnosis date: unknown duration of disease (month): unknown Sex: unknown fab: unknown bone marrow myeloblast(%): unknown wbc (x10^3/mcl): unknown platelet (x10^3/mcl): unknown hemoglobin (g/dl): unknown anc (x10^3/mcl): unknown iPSs: unknown cytogenetic risk group: unknown cytogenetics: unknown
GSM747442
GPL570
RNA control rep6 CD34+ purified control bone marrow genotype: control disease state: control cell type: CD34+ purified control bone marrow age on study: unknown race: unknown banking date: unknown diagnosis date: unknown duration of disease (month): unknown Sex: unknown fab: unknown bone marrow myeloblast(%): unknown wbc (x10^3/mcl): unknown platelet (x10^3/mcl): unknown hemoglobin (g/dl): unknown anc (x10^3/mcl): unknown iPSs: unknown cytogenetic risk group: unknown cytogenetics: unknown
 
 
Make groups for comparisons
(2 groups will be compared at a time)
Select GSMs and click on "Add groups"
Enter the group name here:


Select expression type
Transcripts profile based on;
A. Differential status (Up/Down regulation)
B. Absolute calls (Transcribed/Not-detected)
 
Filter results by number of probes